Extreme elevation of CA19-9 in patient with endometriosis-associated cancer: A brief report and review of the literature

IF 0.2 Q4 ONCOLOGY
Maia Drasin , Gregory Rumore , Elizabeth Suh-Burgmann
{"title":"Extreme elevation of CA19-9 in patient with endometriosis-associated cancer: A brief report and review of the literature","authors":"Maia Drasin ,&nbsp;Gregory Rumore ,&nbsp;Elizabeth Suh-Burgmann","doi":"10.1016/j.cpccr.2023.100254","DOIUrl":null,"url":null,"abstract":"<div><p>CA 19-9 (carbohydrate antigen 19-9) is used as a biomarker for hepatobiliary cancer and is generally not considered helpful in the evaluation of gynecologic cancer. Endometriosis-associated cancers are a subset of gynecologic cancers in which malignancy is found adjacent to endometriosis either within or outside the gynecologic tract. We describe a case of a woman who presented with a CA 19-9 level of 49,469 U/mL who was subsequently found to have two concurrent but separate primary endometriosis-associated cancers involving the ovary and small intestine. Although data regarding the association between CA 19-9 and endometriosis-associated malignancy is lacking, endometriosis is known to be associated with high levels of inflammation which in turn has been associated with higher CA 19-9 levels. The inflammatory response and effect on CA 19-9 levels may be particularly pronounced in cases where endometriosis-associated malignancy involves the peritoneum. The case described suggests that when cancer is suspected in a woman with an extremely high level of CA 19-9 and no apparent hepatobiliary disease, an endometriosis-associated malignancy may be a consideration.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current problems in cancer. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666621923000388","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

CA 19-9 (carbohydrate antigen 19-9) is used as a biomarker for hepatobiliary cancer and is generally not considered helpful in the evaluation of gynecologic cancer. Endometriosis-associated cancers are a subset of gynecologic cancers in which malignancy is found adjacent to endometriosis either within or outside the gynecologic tract. We describe a case of a woman who presented with a CA 19-9 level of 49,469 U/mL who was subsequently found to have two concurrent but separate primary endometriosis-associated cancers involving the ovary and small intestine. Although data regarding the association between CA 19-9 and endometriosis-associated malignancy is lacking, endometriosis is known to be associated with high levels of inflammation which in turn has been associated with higher CA 19-9 levels. The inflammatory response and effect on CA 19-9 levels may be particularly pronounced in cases where endometriosis-associated malignancy involves the peritoneum. The case described suggests that when cancer is suspected in a woman with an extremely high level of CA 19-9 and no apparent hepatobiliary disease, an endometriosis-associated malignancy may be a consideration.

CA19-9在子宫内膜异位症相关癌症患者中的极端升高:一个简短的报告和文献回顾
CA 19-9(碳水化合物抗原19-9)被用作肝胆癌的生物标志物,通常被认为对妇科癌症的评估没有帮助。子宫内膜异位症相关的癌症是妇科癌症的一个子集,其中恶性肿瘤与子宫内膜异位症相邻,在妇科道内或外。我们描述了一例CA 19-9水平为49,469 U/mL的女性,她随后被发现患有两种并发但单独的原发性子宫内膜异位症相关癌症,涉及卵巢和小肠。虽然缺乏关于CA 19-9与子宫内膜异位症相关恶性肿瘤之间关系的数据,但众所周知,子宫内膜异位症与高水平的炎症有关,而炎症反过来又与较高的CA 19-9水平有关。在子宫内膜异位症相关的恶性肿瘤累及腹膜的情况下,炎症反应和对CA 19-9水平的影响可能特别明显。所描述的病例提示,当CA 19-9水平极高且无明显肝胆疾病的女性怀疑患有癌症时,可能需要考虑子宫内膜异位症相关的恶性肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
审稿时长
96 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信